Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
NCT07695740
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsed or Refractory Multiple Myeloma (RRMM)
Interventions
DRUG:
YKST02
Sponsor
Excyte Biopharma Ltd